Pneumococcal pneumonia (PP) and invasive pneumococcal disease (IPD) are important
causes of morbidity and mortality in seniors worldwide. Incidence rates and serious …

The effective prevention of Streptococcus pneumoniae infection has a renewed priority in an
era in which the emergence of antibacterial-resistant strains has the potential to further …

To overview the present global burden of pneumococcal disease is important because new
preventive measures such as the pneumococcal conjugate vaccine 13 are currently being …

The risk of invasive Streptococcus pneumoniae infection (primarily bacteraemia and
meningitis) is greatest among the very young and the very old. Persons in certain racial …

Pneumococcal polysaccharide vaccine has been licensed for use in the United States for>
30 years, and two-thirds of the elderly population in the United States have received this …

The burden of pneumococcal disease among elderly people is not widely known. In most
countries, the annual incidence of invasive pneumococcal disease in elderly people is most …

Pneumococcal disease in the elderly is a major concern emphasizing the need for
prevention. The review focuses on a literature-based analysis of the efficacy (“does the …

Streptococcus pneumoniae causes considerable morbidity and mortality in the elderly.
There are three established approaches to pneumococcal vaccination: polysaccharide …

Streptococcus pneumoniae remains a major cause of morbidity and mortality throughout the
world. To date, after the introduction of routine childhood immunization, elderly people (ie …

Introduction Streptococcus pneumoniae is a major cause of morbidity and mortality. We
sought to describe the epidemiology of non-invasive and invasive pneumococcal disease in …